OSE Pharma plans IPO on Euronext Paris

Orphan Synergy Europe-Pharma S.A. plans an IPO on Euronext Paris by year end to fund clinical trials of its immunotherapy Tedopi.

Tedopi is a combination of 10 epitopes targeting five tumor-associated antigens often found in late-stage cancers. ...